Product Overview

Jonpiolee 30 contains Pioglitazone Hydrochloride, a thiazolidinedione (TZD) class oral antidiabetic medication developed for the effective management of Type 2 Diabetes Mellitus. It is widely prescribed to improve glycemic control in adults whose blood glucose levels are not adequately controlled through diet, exercise, and lifestyle modifications alone. Pioglitazone is recognized for its ability to improve insulin sensitivity, making it an important component of modern diabetes management.

Unlike medications that primarily stimulate insulin secretion, Pioglitazone works by increasing the body’s sensitivity to naturally produced insulin, allowing glucose to be utilized more efficiently by muscle and fat tissues while reducing glucose production by the liver. This mechanism helps maintain stable blood glucose levels and supports long-term metabolic control.

Jonpiolee 30 may be prescribed as monotherapy or in combination with other oral antidiabetic medications or insulin, depending on the patient’s clinical condition and treatment requirements. It is commonly incorporated into comprehensive diabetes management plans that include dietary modifications, regular physical activity, and routine blood glucose monitoring.

Manufactured under stringent pharmaceutical quality standards, Jonpiolee 30 provides consistent efficacy, safety, and reliability, making it a trusted therapeutic option for healthcare professionals managing Type 2 Diabetes Mellitus.

How It Works

Pioglitazone Hydrochloride activates peroxisome proliferator-activated receptor gamma (PPAR-γ), improving the body’s sensitivity to insulin in muscle, adipose tissue, and the liver. This action enhances glucose uptake by peripheral tissues, reduces hepatic glucose production, and helps maintain stable blood glucose levels without directly stimulating insulin secretion.

Therapeutic Applications

Jonpiolee 30 may be prescribed for the management of:

• Type 2 Diabetes Mellitus
• Insulin Resistance
• Long-Term Glycemic Management
• Blood Glucose Control
• Combination Therapy with other Antidiabetic Medications
• Patients inadequately controlled by diet and exercise alone

Key Benefits

• Improves insulin sensitivity and glucose utilization.
• Helps lower blood glucose levels effectively.
• Supports long-term glycemic control.
• Suitable for monotherapy or combination antidiabetic therapy.
• Convenient once-daily oral treatment.
• Manufactured under stringent pharmaceutical quality standards.

Quality Commitment

Vinix Biopharma is committed to delivering high-quality antidiabetic medicines manufactured in accordance with stringent pharmaceutical quality standards. Jonpiolee 30 undergoes comprehensive quality assurance and rigorous testing to ensure safety, efficacy, consistency, and reliability. Every batch is carefully evaluated to maintain product integrity and support optimal patient care.

Storage Information

Store in a cool, dry place below 30°C. Protect from moisture and direct sunlight. Keep out of reach of children.

Disclaimer

Jonpiolee 30 should be used only under the supervision of a qualified healthcare professional. Dosage and duration of treatment should be determined by the treating physician based on the patient’s clinical condition, medical history, and therapeutic requirements.